Vizibl has appointed Jim Massey to lead Vizibl’s Strategic Advisory Board. As a senior Strategic Advisor, Jim will assist Vizibl in developing its sustainability solutions and services.
Jim joins Vizibl with nearly 25 years’ experience in the ESG, sustainability, and compliance sectors. Jim has held leadership roles at MedImmune and AstraZeneca, where he served as Vice President of ESG, Sustainability, Ethics and Compliance. He subsequently became a Senior Advisor at Route 2, before moving into his current full-time role as Chief Sustainability Officer at biopharmaceutical company, Zai Lab.
Massey said: “Organisations need technology partners that help them to challenge the environmental, social and governance status quo, and to think differently about how to use sustainability as a business enabler. I’m excited about working with my fellow advisors to help Vizibl to drive that change forward through its innovative and visionary solution stack, while helping it to meet its short and long-term goals.”
Mark Perera, CEO of Vizibl, adds: “Jim will be a great asset to the Vizibl team. His experience, passion and drive for ESG initiatives is second to none – he understands the value and importance of embedding sustainability within the fabric of an organisation and its supply chain. Enterprise organisations are rapidly realising that Supplier Collaboration is no longer a ‘nice to have’, it is business critical, and they simply cannot tackle their Scope 3 climate commitments in isolation. We’re thrilled to welcome Jim as an advisor and his vast body of experience will deliver value to both the Vizibl business and the customers we serve.”
Read the latest edition of PCR’s monthly magazine below: